MENU
+Compare
SCYX
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$0.59
Change
-$0.00 (-0.00%)
Capitalization
24.76M

SCYX SCYNEXIS Forecast, Technical & Fundamental Analysis

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs... Show more

SCYX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SCYX with price predictions
Nov 12, 2025

SCYX in downward trend: 10-day moving average crossed below 50-day moving average on October 08, 2025

The 10-day moving average for SCYX crossed bearishly below the 50-day moving average on October 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SCYX as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCYX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SCYX entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SCYX advanced for three days, in of 232 cases, the price rose further within the following month. The odds of a continued upward trend are .

SCYX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.680) is normal, around the industry mean (18.827). P/E Ratio (0.905) is within average values for comparable stocks, (71.764). SCYX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). SCYX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (9.950) is also within normal values, averaging (39.291).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SCYX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCYX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
SCYX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SCYX is expected to report earnings to fall 162.76% to 10 cents per share on April 01

SCYNEXIS SCYX Stock Earnings Reports
Q4'25
Est.
$0.11
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.10
Q4'24
Beat
by $0.06
The last earnings report on November 05 showed earnings per share of -17 cents, beating the estimate of -20 cents. With 408.56K shares outstanding, the current market capitalization sits at 24.76M.
A.I. Advisor
published General Information

General Information

a company which engages in discovery, development and commercialization of novel anti infectives

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1 Evertrust Plaza
Phone
+1 201 884-5485
Employees
29
Web
https://www.scynexis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDCM13.320.65
+5.13%
Radcom Ltd
LVWR4.970.14
+2.90%
LiveWire Group
WFG59.901.08
+1.84%
West Fraser Timber Co Ltd
KMI27.010.07
+0.26%
Kinder Morgan
SVRE1.01-0.05
-4.72%
SaverOne 2014 Ltd

SCYX and Stocks

Correlation & Price change

A.I.dvisor tells us that SCYX and SIGA have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCYX and SIGA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
-1.70%
SIGA - SCYX
28%
Poorly correlated
-1.27%
ACET - SCYX
27%
Poorly correlated
+6.24%
ELAN - SCYX
27%
Poorly correlated
-3.54%
AQST - SCYX
26%
Poorly correlated
-1.93%
CRON - SCYX
25%
Poorly correlated
+0.79%
More

Groups containing SCYX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
-1.70%
Pharmaceuticals: Generic
industry (214 stocks)
25%
Poorly correlated
-1.00%